Larimar Therapeutics Inc share price logo

Larimar Therapeutics Inc Share Price

NASDAQ: LRMR

Small Cap

$4.49

+0.02

(+0.45%)

as on

Larimar Therapeutics Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.41
    $4.92
    downward going graph

    1.78%

    Downside

    9.58%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.61
    $6.42
    downward going graph

    64.14%

    Downside

    42.98%

    Upside

    downward going graph

Larimar Therapeutics Inc share price movements today

Previous Close
$4.47
Open
$4.50
Volume
2.5M
Day's Low - High
$4.41 - $4.92
52 Week Low - High
$1.61 - $6.42

Larimar Therapeutics Inc Historical Returns

1 Month Return
+ 51.18 %
3 Month Return
+ 23.01 %
1 Year Return
+ 76.77 %
3 Year Return
-5.47 %
5 Year Return
-75.37 %

Larimar Therapeutics Inc Stock Fundamentals & Key Indicators

Check Larimar Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$463.0M

EPS (TTM)

-1.993

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-139.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-78.24%

Larimar Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Larimar Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Larimar Therapeutics Inc image
Larimar Therapeutics Inc
BUY$463.0M-75.37%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Larimar Therapeutics Inc Stock including INR - Dollar returns

The Larimar Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Larimar Therapeutics Inc investment value today

Current value as on today

₹1,86,217

Returns

₹86,217

(+86.22%)

Returns from Larimar Therapeutics Inc Stock

₹76,772 (+76.77%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Larimar Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Larimar Therapeutics Inc. Average target price of $16.6

Larimar Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Larimar Therapeutics Inc.

What analysts predicted

72.95%UPSIDE

Target Price

$16.6

Current Price

$4.49

Analyzed by

12 Analysts

Target

$16.60

Larimar Therapeutics Inc target price $16.6, a slight upside of 72.95% compared to current price of $4.49. According to 12 analysts rating.

Larimar Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Larimar Therapeutics Inc Shares on INDmoney has grown by 5100.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:5100.00% versus previous 30 day period

Search interest for Larimar Therapeutics Inc Stock has increased by 4100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4100% versus previous 30 day period

Larimar Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-9
-10
-14
-16
-24
-18
-31
-31
-27
-49
EBITDA
-9
-10
-14
-16
-24
-18
-31
-31
-27
-47
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-9
-12
-14
-21
-15
-28
-29
-26
-47
Income Tax Expense
0
0
0
0
-
0
-
-
-
-
Net Income
-8
-9
-12
-14
-21
-15
-28
-29
-26
-47
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-5980.08%
0.00%
0.00%
0.00%

Larimar Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
Operating Income
-23
-42
-50
-36
-41
-90
EBITDA
-23
-42
-50
-36
-41
-90
Interest Expense
1
-
0
0
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-23
-42
-50
-35
-36
-80
Income Tax Expense
0
0
0
-1
-
-
Net Income
-23
-42
-50
-34
-36
-80
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Larimar Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-9
-12
-14
-21
-15
-28
-29
-26
-47
Operating Cash Flow
-9
-9
-10
-13
-24
-21
-26
-19
-28
Investing Cash Flow
-46
-2
-68
-63
27
19
14
18
33
Financing Cash Flow
0
-
162
0
0
0
-
-
65
Change in Cash
-55
-11
83
-77
2
-2
-12
0
69

Larimar Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-57
-52
-61
-23
-42
-50
-35
-36
-80
Operating Cash Flow
-51
-43
-51
-22
-42
-42
-27
-33
-70
Investing Cash Flow
51
35
-6
0
17
24
-90
33
-85
Financing Cash Flow
-2
16
66
19
93
19
75
0
161
Change in Cash
-3
8
8
-48
68
1
-43
0
5

Global Institutional Holdings in Larimar Therapeutics Inc

Funds
Holdings
RA Capital Management, LLC
7.06%
Driehaus Capital Management LLC
0.52%
AQR Capital Management LLC
0.54%
Deerfield Management Co
29.55%
Vanguard Group Inc
2.94%
See all

Insights on Larimar Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LRMR has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LRMR stock has moved up by 51.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LRMR has outperformed top 5 stocks with highest market-cap in its industry

About Larimar Therapeutics Inc

larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company’s lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich’s ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. for more information, please visit: https://larimartx.com.
OrganisationLarimar Therapeutics Inc
HeadquartersThree Bala Plaza East, Bala Cynwyd, PA, United States, 19004
IndustryHealth Technology
CEODr. Carole S. Ben-Maimon M.D.
E-voting on sharesClick here to vote

Key Management of Larimar Therapeutics Inc

Name

Title

Mr. Michael Celano CPA

Secretary & CFO

Dr. Gopi Shankar M.B.A., Ph.D.

Chief Development Officer

Mr. John Berman

Vice President of Finance & Administration

Ms. Jennifer Spokes Johansson

Vice President of Legal & Compliance

Dr. Russell G. Clayton Sr., D.O.

Chief Medical Officer

Mr. Francis Michael Conway CPA

VP & Controller

Dr. Carole S. Ben-Maimon M.D.

CEO, President & Director

FAQs

What is Larimar Therapeutics Inc share price today?

Larimar Therapeutics Inc share price today is $4.49 as on at the close of the market. Larimar Therapeutics Inc share today touched a day high of $4.92 and a low of $4.41.

What is the 52 week high and 52 week low for Larimar Therapeutics Inc share?

Larimar Therapeutics Inc share touched a 52 week high of $6.42 on and a 52 week low of $1.61 on . Larimar Therapeutics Inc stock price today i.e. is closed at $4.49,which is 30.06% down from its 52 week high and 178.88% up from its 52 week low.

What is Larimar Therapeutics Inc's market capitalisation today?

Larimar Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Larimar Therapeutics Inc Stock (LRMR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Larimar Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Larimar Therapeutics Inc Shares that will get you 0.3341 shares as per Larimar Therapeutics Inc share price of $4.49 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Larimar Therapeutics Inc Stock (LRMR) from India?

Indian investors can start investing in Larimar Therapeutics Inc (LRMR) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Larimar Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Larimar Therapeutics Inc share’s latest price of $4.49 as on March 21, 2026 at 1:29 am IST, you will get 2.2272 shares of Larimar Therapeutics Inc. Learn more about fractional shares .

What are the returns that Larimar Therapeutics Inc has given to Indian investors in the last 5 years?

Larimar Therapeutics Inc stock has given -75.37% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?